The BALB/c mouse model for human respiratory syncytial virus infection has contributed significantly to our understanding of the relative role for CD4 + and CD8 + T cells to immune protection and pathogenic immune responses. To enable comparison of RSV-specific T cell responses in different mouse strains and allow dissection of immune mechanisms by using transgenic and knockout mice that are mostly available on a C57BL/ 6 background, we characterized the specificity, level and functional capabilities of CD8 + T cells during primary and secondary responses in lung parenchyma, airways and spleens of C57BL/6 mice. During the primary response, epitopes were recognized originating from the matrix, fusion, nucleo-and attachment proteins, whereas the secondary response focused predominantly on the matrix epitope. C57BL/6 mice are less permissive for hRSV infection than BALB/c mice, yet we found CD8 + T cell responses in the lungs and bronchoalveolar lavage, comparable to the responses described for BALB/c mice.
Introduction
Respiratory syncytial virus (RSV), a member of the family of Paramyxoviridae, is the leading cause of viral lower respiratory tract infection in early childhood. Although about 50 years have elapsed since the virus was discovered, the essential parameters that determine a severe disease course during primary infection have not been unambiguously identified. Besides the burden RSV infections pose on the population during primary disease, which is usually attracted during the first year of life, the virus also causes recurrent reinfections which are a main health concern in elderly people and immune compromised individuals (Falsey et al., 2005) . Moreover, RSV lower respiratory tract disease is followed by recurrent episodes of wheezing in a considerable population of children (Bont et al., 2004) . A safe and effective vaccine is not available. A dramatic vaccine trial was performed in the 1960s with formalin inactivated RSV (FI-RSV). Vaccinees in this trial developed enhanced disease upon exposure to the natural virus (Kim et al., 1969; Chin et al., 1969) . For the development of future vaccines that are highly protective and safe, two essential points need to be addressed. First, how can immune-mediated enhancement of disease be prevented? And second, why is immunity incomplete after natural RSV infection and how can this be improved by a vaccine?
Several aspects of the immune response against RSV including the enhanced disease mechanism after FI-RSV vaccination have been extensively studied in mouse models, Virology 352 (2006) 157 -168 www.elsevier.com/locate/yviro particularly in BALB/c, a mouse strain highly permissive to hRSV infection (Prince et al., 1979; Waris et al., 1996) . From these studies, it was learned that CD4 + Th2 cells are a crucial component of enhanced disease characterized by an eosinophilic influx in the lungs that was also observed in FI-RSV vaccinated children (Connors et al., 1992) . The effect of this Th2 response could be antagonized by an effective simultaneous CD8 + T cell response, whereby high production of IFN-γ seemed crucial (Srikiatkhachorn and Braciale, 1997; Hussell et al., 1997) .
Another finding in BALB/c mice was that CD8 + T cells in the lung tissue were partially functionally inactivated. This conclusion was made from the observation that in the same lung-derived cell sample, the number of CD8 + T cells specific for a certain viral epitope as measured by H-2 tetramer staining did not match up with the number of CD8 + T cells that produced IFN-γ upon an ex vivo stimulus with the same peptide (Chang and Braciale, 2002) . This discrepancy was not found in splenic cell samples but only found in lung tissue when live virus was present. The authors suggested that this functional impairment of the CD8 + T cell response might have some relation with the incomplete long-term memory against RSV (Chang and Braciale, 2002) . The mechanism by which CD8 + T cells became inactivated is unclear. In in vitro responses with human T cells, high surface expression of the F protein on accessory cells was reported to impair the proliferative response of T cells induced by a polyclonal stimulus (Schlender et al., 2002) . However, others have suggested the role of soluble factors as the cause for impaired polyclonal T cell activation in the presence of live RSV (Salkind et al., 1991; Preston et al., 1995; de Graaff et al., 2005) .
Genetic factors have been shown to affect susceptibility to primary hRSV infection in mice as well as the nature of the secondary immunological response to RSV infection after vaccination (Hussell et al., 1998; Prince et al., 1979; Stark et al., 2002) . MHC genes and non-MHC genes both played a crucial role in disease severity. Hence, the detailed study of T cell responses in other mice strains besides BALB/c might further our understanding of the mechanisms leading to protective immunity or immune pathology. C57BL/6 mice have been studied in various infection models in parallel to BALB/c mice. From these studies, it has become clear that for certain pathogens BALB/c mice are more prone to develop a Th2 skewed immune response whereas C57BL/6 mice elicit Th1 type responses (Sacks and Noben-Trauth, 2002; Guinazu et al., 2004; Lenzo et al., 2003) . This essential difference in pathogenspecific immune responses as well as the fact that many interesting transgenic and knockout mice are available on an H-2 b background determined our choice to characterize the CD8 + T cell response against RSV in the C57BL/6 mouse model.
Results

Identification of H-2 b -restricted epitopes of RSV proteins by Elispot
It has been reported that CD8 + T cells in the lungs of BALB/ c mice are functionally inactivated. To be able to judge whether this observation can be generalized to other mouse strains and to study the mechanism of anti-viral T cell activation using transgenic or KO mouse models, it was necessary to identify CD8 + T cell epitopes in a different mouse strain. Because many interesting genetically manipulated mice are available on an H-2 b background, we initiated an epitope search in C57BL/6 mice. A panel of 18-mer peptides (12 amino-acid overlap) of the RSV-F protein as well as a set of peptides derived from other RSV proteins, predicted by algorithms for the MHC class I allele H-2D b were synthesized (Table 1) (Rammensee et al., 1999; Parker et al., 1994 ). We initially focused on H-2D b because it appeared to be the main restriction element during RSV infection in H-2 b mice (Hussell et al., 1998) . Splenocytes from RSV-infected C57BL/6 mice were isolated 8 days after primary infection and were stimulated with the synthetic peptides. The peptides were tested for their capability to induce IFN-γ production by T cells in an Elispot assay. The number of spotforming cells (SFC) per 10 6 cells was determined (Fig. 1) . The 18-mer peptide set was initially tested as mixtures of 6 consecutive peptides, followed by tests with individual peptides of positive pools. The most dominant response in C57BL/6 was directed against the M 187-195 sequence, derived from the matrix protein. We further found substantial responses against two sequences from the Fusion protein (F 250-258 and F 433-450 ), one from the nucleoprotein (NP [360] [361] [362] [363] [364] [365] [366] [367] [368] ) and a response against a peptide representing amino acid residues 177-194 from the G protein (G 177-194 ).
Identified epitopes are recognized by CD8 + T cells
Because of the length of some of the peptides, the observed responses in the Elispot assay could reflect CD4 + and/or CD8 + T cell responses. Therefore, intracellular cytokine staining (ICS) was performed to elucidate the role of CD4 + versus CD8 + T cells. Peptides that gave a strong positive result with the Elispot assay, as well as an extra peptide derived from the NP sequence that was predicted to bind to H-2K b and a shorter variant of the sequence from the G protein, were used. represented the nonamer contained in the two overlapping peptides F 241-258 and F 247-264 that were identified by Elispot. Lung lymphocytes from C57BL/6 mice isolated 8 days after primary infection were stimulated for 6 h with the peptides. The T cells to produce IFN-γ. Peptides derived from the NP and F proteins induced IFN-γ production, involving 2.3-8% of the lung CD8 + T cells. In BALB/c mice, the lack of a G-specific CD8 + T cell response after viral infection has been well documented (Srikiatkhachorn and Braciale, 1997; Alwan et al., 1994) . Interestingly, we found that the response against the peptides derived from the G protein were like the other responses also CD8 + T cell mediated, with 8% of the CD8 + T cells in lung responding to the G [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] peptide to near background levels, whereas pre-incubation with anti-K b or the VSV NP 52-59 had no effect on the G 177-194 -induced IFN-γ production (Fig.  2B ). This result proved that the observed IFN-γ production stimulated by G [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] was a genuine CD8 + T cell response.
The M [187] [188] [189] [190] [191] [192] [193] [194] [195] -specific primary CD8 + T cell responses in the lungs at day 8 post-infection
In BALB/c mice, it has been shown that the pulmonary RSVspecific CD8 + T cell responses display a partially inactivated phenotype (Chang and Braciale, 2002; Chang et al., 2001 ). To determine whether a similar phenomenon happened in RSVinfected C57BL/6 mice, we compared M [187] [188] [189] [190] [191] [192] [193] [194] [195] tetramer and intracellular IFN-γ staining. Lung lymphocytes were stained with an M 187-195 tetramer and antibodies specific for the activation markers CD11a and CD62L or NKG2a. These antibodies were used to estimate the total number of recently activated T cells present in the sample. In the lung tissue of C57BL/6 mice undergoing a primary RSV infection, 46% of the CD8 + T cells were activated as measured by up-regulation of NKG2a expression ( Fig. 2C ; Table 2 ). This was similar to the percentage of CD8 + T cells that had a CD11a hi and CD62L low phenotype (49%). In MOCK-infected mice, only 4.5% (average 3.1 ± 0.9%) of the CD8 + T cells in the lung had an activated phenotype.
M [187] [188] [189] [190] [191] [192] [193] [194] [195] tetramer staining revealed that 13% (12% average, Table 3 ) of the CD8 + T cells in the lung stained positive (Fig.  2D ). The background staining was only 0.27% in a MOCKinfected mouse and 0.29% in a mouse going through a primary influenza infection confirming the specificity of the tetramer. In influenza-infected control mice, CD8 + T cells stained positive (11%) with an influenza NP 366-374 tetramer, which showed that these mice had been properly infected. The M 187-195 -specific response involved 28% of the CD11a hi /CD62L low population of CD8 + T cells in the lung tissue. Fig. 2E shows that virtually all tetramer-positive cells indeed had the activated phenotype (CD11a hi , CD62L low , NKG2A pos ). Thus, our data clearly showed that the number of tetramer-positive cells was similar to the number of cells that produced IFN-γ after in vitro stimulation with the peptide (Table 3) . Hence, in the C57BL/6 mouse strain, at day 8 after primary infection, we did not observe the discrepancy found by Chang and Braciale (2002) between the number of tetramer-positive and the number of functional cells.
Transition of CD8 + T cells from effector to memory cells in the lungs
To evaluate the possible inactivation of M-specific CD8 + T cells during the transition of effector phase to the early memory phase, we removed lung lymphocytes from mice 21 days p.i. and stimulated these cells with the same epitopes used at day 8 p.i. The total number of T cells recovered from the lungs at day 21 was twofold lower than at day 8. The percentage of CD8 + T cells that produced IFN-γ also declined. The M 187-195 peptide still was the dominant epitope, with 5% of the CD8 + T cells producing IFN-γ. The other peptides induced IFN-γ production that hardly reached above background levels (Figs. 3A and 5C). To study the activation status of these cells at this time point, we stained the cells with the activation markers and the M [187] [188] [189] [190] [191] [192] [193] [194] [195] tetramer. There was a decline in the percentage of activated CD8 + T cells, with about 38% (33% average in the group; Fig. 3C ; Table 3 ). Thus, at this time point we found a discrepancy between the cells able to produce IFN-γ and the cells that stained positive with the tetramer indicating Fig. 1 . Identification of immunodominant domains in RSV proteins. Mice were intranasally infected with RSV, and 8 days later splenic lymphocytes were incubated with 10 μg/ml synthetic peptides. T cells responding to synthetic peptides in the cultures were enumerated with an IFN-γ Elispot assay. The results from the positive pools, one negative pool and individual peptides are shown. Error bars represent the standard error of the mean (SEM), results are triplicate measurements of 1 mouse. An identical response pattern was observed in three individual mice. The numbers given for the pools identify the stretch of amino acid residues that is covered by the peptides in the pools.
that in time, a fraction of RSV-specific lung T cells lost the capacity to produce IFN-γ in C57BL/6 mice.
Functional inactivation of M 187-195 -specific CD8 + T cells in the lungs
The inability of the M 187-195 -specific CD8 + T cells of the lungs to produce IFN-γ at day 21 after infection was studied in more detail. To confirm that the inactivation was tissue specific and not caused by technical procedures, we compared the M 187-195 -specific CD8 + T cell response in the spleen and lungs at days 8, 21 and 28. According to the report by Chang and Braciale (2002) , the effect of CD8 + T cell inactivation is restricted to the lungs. The percentage of M 187-195 -specific CD8 + T cells in the lung parenchyma at day 8 was comparable with the percentage of CD8 + T cells producing IFN-γ after peptide stimulation, 12.1% tetramer-positive versus 12.5% IFN-γ producing CD8 + T cells (Table 3) . This was also observed for CD8 + T cells in the spleen at day 8, where 1.4% stained positive with the M 187-195 tetramer and 1.6% produced IFN-γ after peptide stimulation.
As already observed, there was a discrepancy between M 187-195 tetramer-specific CD8 + T cells and the number of these cells capable of producing IFN-γ at day 21 from the lung parenchyma. Only 59% of the M 187-195 -specific CD8 + T cells produced IFN-γ, in contrast to the spleen where all M 187-195 -specific CD8 + T cells produced IFN-γ at day 21 after stimulation with the M 187-195 peptide (Table 3) . The difference between M 187-195 IFN-γ production and M [187] [188] [189] [190] [191] [192] [193] [194] [195] tetramer staining of CD8 + T cells in the lung parenchyma increased even more at day 28 after primary infection. Only 41% of the M 187-195 -specific CD8 + T cells in the lung parenchyma were functional, whereas 83% of these cells in the spleen were functional.
RSV-specific responses in bronchoalveolar lavage
In addition to the immune response in the lung parenchyma, we also studied the RSV-specific response by the pulmonary inflammatory cells in the lung airways 8 and 21 days after RSV infection (Fig. 4) . We eluted these cells by bronchoalveolar lavage and examined the activation status of these cells. In the BAL at day 8, about 75% (69% average in the whole group) of the CD8 + T cells could be identified as activated with an NKG2a pos , CD11a hi and CD62L low phenotype ( Fig. 4A ; Table  2 ). Of the CD8 + T cells in the BAL, 20% stained positive with the M 187-195 tetramer, with all the tetramer-positive cells being NKG2a pos , CD11a hi and CD62L low ( Fig. 4A ; Table 3 ). When we applied the same procedure at day 21 postinfection, the majority (81% average in the group; + T cells from the lung parenchyma into lung airways, where the expression of CD11a is progressively lost. When we looked at the functional responses in the BAL, initially at day 8 after primary infection, the ratio IFN-γ versus tetramer-positive cells was higher than in the lung parenchyma. However, at day 28 the functional inactivation was also found in the BAL (Table 3) .
Secondary M 187-195 -specific CD8 + T cell responses in the lungs
The hierarchy of CD8 + T cell immune responses can change after a secondary infection. To test if there was a difference in hierarchy after a secondary RSV infection in the C57BL/6 RSV model, we infected C57BL/6 mice with RSV and 4 weeks later they were intranasally challenged with the same dose of RSV. The lung parenchyma and splenic CD8 + T cells were analyzed 6 days after challenge for their capability to produce IFN-γ after The average values of tetramer-positive cells and SEM of the total group can be found in Table 3 . Fig. 5C ) of the CD8 + T cells producing IFN-γ after stimulation (Fig. 5A) . Furthermore, the results showed that the NP 360-368 epitope was the second dominant epitope with 4.2% IFN-γ-positive CD8 + T cells. There was no clear hierarchy a Denotes significant difference between day 8 lung parenchyma and lung airways (P < 0.001).
b Denotes values that significantly differ from day 8 (P < 0.001). between the other epitopes; however, NP 57-64 and F 433-442 hardly stimulated any IFN-γ production. Results obtained with control mice undergoing a primary MOCK infection that were challenged 4 weeks later with RSV had 4.3 ± 1.3% of the lung CD8 + T cells producing IFN-γ after M 187-195 stimulation on day 6 p.i. (Fig. 5B) . This showed that during a "primary" infection on day 6, the response against the M 187-195 epitope was significantly lower compared with 14% IFN-γ production after M [187] [188] [189] [190] [191] [192] [193] [194] [195] stimulation during a recall response. Fig. 5C summarizes the observed CD8 + T cell response (average values of the groups) for the different epitopes at several time points and clearly shows that the secondary response in all the mice was less heterogeneous in the lung parenchyma than the primary response. The substantial responses against the G [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] epitopes observed during the primary response was not found during the secondary response. In contrast, more CD8 + T cells responded to NP 360-368 during the secondary response than during the primary response. The boost in the secondary response was not observed in the spleen.
Discussion
CD8
+ cytotoxic T lymphocytes play a crucial role in the clearance of RSV infections in humans and in mice. However, most of the studies in the mouse model have been performed in the BALB/c strain, leaving open the question whether important phenomena, such as the functional inactivation of lung CD8 + T cells (Chang and Braciale, 2002) , are strain specific or will also occur in mice with different genetic backgrounds. To address such questions, we have identified a panel of H-2 brestricted CD8 + T cell epitopes derived from the M, NP, F and G proteins of RSV A2. The M 187-195 epitope was recently reported by Rutigliano et al. (2005) . This group discovered only the M 187-195 epitope, probably because they used as a T cell source, spleen cells derived from C57BL/6 mice after secondary virus infection. In the present paper, we observed an altered epitope hierarchy during primary and secondary RSVspecific T cell responses, whereby the secondary response was indeed dominated by CD8 + T cells responding to the M 187-195 epitope. Such altered hierarchy in epitope recognition during Table 2. primary and secondary responses has also been described for influenza epitopes, where it appeared to be the result of differences in epitope expression by different antigen presenting cell types (Crowe et al., 2003 b , although H-2D b was found to be the restriction element by means of antibody blocking and peptide competition studies. However, attempts to identify the minimal G epitope were unsuccessful. Contamination with one of the other peptides could be excluded by mass spectrometry (ms) and tandem mass spectrometric sequencing. We are currently working on different approaches to solve the structure of the naturally presented G peptide.
The fact that we found a G-derived peptide that was recognized by CD8 + T cells was interesting because many reports suggested that the G protein is poorly recognized by CD8 + T cells (Bangham et al., 1986; Srikiatkhachorn and Braciale, 1997; Nicholas et al., 1990) . In BALB/c mice, the Gspecific CD8
+ T cell response is clearly absent. This lack of an H-2 b -restricted G-specific CD8 + T cell response has been held responsible for the enhanced CD4 + Th2 response causing lung eosinophilia after vaccination employing the G protein as sole RSV component (Alwan et al., 1994; Srikiatkhachorn and Braciale, 1997) . Interestingly, the same priming procedure did not lead to the enhanced disease in C57BL/6 mice (Hussell et al., 1998) . The presence or absence of CD8 + T cell responses directed against the G protein in different mouse strains that are relatively resistant to eosinophilic lung disease has not been extensively studied. A possible explanation for the resistance of C57BL/6 mice for enhanced disease after G priming could be the presence of the CD8 + T cell epitope in the G protein. This CD8 epitope might elicit a memory T cell response that could be sufficient to regulate the CD4 + T cell response upon viral challenge.
Eight days after primary intranasal infection with RSV, more than 12% of the CD8 + T cells in the lungs recognized the dominant M [187] [188] [189] [190] [191] [192] [193] [194] [195] peptide. In several reports, it has been shown that NKG2a is up-regulated by CD8 + T cells after contact with antigen and remains expressed long after (Moser et al., 2002) . This marker was therefore used as a surrogate activation marker for antiviral CD8 + T cells (Gold et al., 2004; Claassen et al., 2005 + T cells in the lungs of C57BL/6 mice were fully functional at day 8 after infection (Chang and Braciale, 2002) . If we would assume that also for the other epitopes T cells were fully functional at day 8, this would suggest that the epitopes we have characterized together amount to at least >95% of the virus-specific responses as measured by the total number of NKG2a pos , CD11a high and CD62L low CD8 + T cells. The memory response against RSV is usually incomplete and individuals can be re-infected within a short period with the same strain (Hall et al., 1991) . One possible explanation for the inefficient induction of T cell memory might be the CD8 + T cell inactivation that occurs in RSV-infected lungs that was observed in BALB/c mice (Chang and Braciale, 2002) . When we studied the transition from effector to early memory phase at days 21 and 28 post-infection in C57BL/6 mice, we found that the decline in IFN-γ producing CD8 + T cells was greater than the decline in activated CD8 + T cells defined as NKG2a pos , CD11a hi and CD62L low . Tetramer staining at these time points showed that M [187] [188] [189] [190] [191] [192] [193] [194] [195] CD8 + T cells were present, but they started to lose their functional response, like it was described for CD8 + T cell responses in the lungs of RSV-infected BALB/c mice. The effect of functional inactivation on viral clearance is yet to be determined. However, we showed that upon secondary infection to RSV a robust recall response could be measured against the matrix epitope. These matrix-specific T cells could potentially contribute to viral clearance.
Functional inactivation has also been described for other viruses from the Paramyxoviridae family (Gray et al., 2005 ; Chang and Braciale, 2002; Claassen et al., 2005) . The fact that the decrease of function started later during primary RSV infection in C57BL/6 mice might be explained by a lower replication of RSV in the lungs of C57BL/6 mice compared with BALB/c mice. Interestingly, Ostler et al. found a more delayed decrease in the number of functional T cells in RSVinfected BALB/c mice lungs than Chang et al. (2001) , which may be related to differences in levels of virus replication reached in the experiments performed by both groups (Ostler and Ehl, 2002; Chang and Braciale, 2002) . Furthermore, our observation that functional inactivation increases over time is in agreement with findings for RSV, pneumonia virus of mice (PVM) and simian virus 5 (SV5) infections in BALB/c mice (Chang and Braciale, 2002; Gray et al., 2005; Claassen et al., 2005) .
In contrast to the lower numbers of epitope-specific cells detected with the intracellular cytokine staining assay compared to the direct tetramer staining in the lung parenchyma, we found the opposite in the BAL, that is, higher numbers of IFN-γ producing cells than tetramerpositive cells (Table 3) . A possible explanation for this observation could be that in the BAL CD8 + T cells had been recently exposed to antigen, which leads to initial T cell receptor down-regulation followed by re-expression. As a result, tetramer staining may be ineffective because the distribution of the T cell receptors on the cell surface may be diffused in the early phase of re-expression although the functional responses triggered by antigenic peptides are effective (Drake et al., 2005) .
In conclusion, we have identified a panel of MHC class I epitopes from the F, M, NP and G protein of RSV A2. The responses against the dominant M 187-195 are fully functional at day 8 during a primary infection. However, at later time points, part of the cells become functionally inactive when triggered via the T cell receptor with cognate antigen. The number of dysfunctional cells increased over time, which was in agreement with observations made for other members of the Paramyxoviridae family. However, our data also suggest that the kinetics of inactivation differs between C57BL/6 and BALB/c mice, and it is tempting to speculate that this may be driven by different viral loads.
Materials and methods
Mice
Pathogen-free 6-to 8-week-old female C57BL/6cjo were purchased from Charles River Nederland (Maastricht, The Netherlands). The mouse study protocols were approved by the Animal Ethics Committee of the Medical Faculty of the Utrecht University.
Viruses and infections
RSV A2 strain was grown in HEp-2 cells, purified by PEG precipitation and stored in liquid nitrogen in 25% sucrose in PBS. Mice were lightly anesthetized with ether and intranasally infected with 2.5 × 10 6 p.f.u. RSV in a volume of 50 μl or with 1 hemagglutination unit influenza A/NT/60/68 in 50 μl diluted in PBS with 10% sucrose.
Peptides
The RSV proteome with the exception of the L protein was screened for predicted epitopes for the H-2D b and the H-2K b alleles, using the algorithms for epitope prediction of the SYFPEITHI (http://www.syfpeithi.de) (Rammensee et al., 1999) and BIMAS Web sites (http://www.bimas.dcrt.nih.gov/ molbio/hla_bind/) (Parker et al., 1994) . Only predicted epitopes present in the top ten in both databases were synthesized and screened (Table 1 ). All peptides were synthesized by standard solid-phase Fmoc chemistry. In recent work, we had prepared a set of overlapping 18 amino acid long peptide amides that overlapped by 12 residues, spanning the entire F protein (van Bleek et al., 2003) .
Tissue sampling
Mice were sacrificed by i.p. injection of 300 μl pentobarbital. Effector cells from the lung airways were obtained by performing a bronchoalveolar lavage (BAL) with 5 × 1 ml of 0.15 M NaCl. Prior to removal, the lungs were perfused with PBS containing 100 U/ml heparin. Lungs were sliced to 1 × 1 mm pieces that were incubated for 30 min at 37°C with collagenase (2.4 mg/ml; Roche Applied Science, Basel, Switzerland) and DNAase (1 mg/ml; Roche Applied Science, Basel, Switzerland). Single cell suspensions were prepared from the pre-treated lungs and spleen by processing the tissue trough cell strainers. Spleen cells were depleted of erythrocytes by treatment with buffered ammonium chloride solution.
Elispot assay
The IFN-γ Elispot assay was performed on splenocytes of mice obtained 8 days after primary infection, using the mouse IFN-γ Elispot pair (U-cytech, Utrecht, The Netherlands) and Multiscreen-IP filter plates (Millipore, Billerica, MA) according to the manufacturers instructions. Cells were stimulated in 200 μl IMDM (Gibco, Invitrogen) containing 10% FCS, penicillin/streptomycin and 50 μM 2-mercapto-ethanol with 10 μg/ml peptide for 24 h at 37°C, 5% CO 2 .
Intracellular cytokine staining (ICS)
For ICS analysis, single cell suspensions of BAL, lung and spleen cells (10 6 ) were stimulated for 6 h at 37°C, 5% CO 2 with 1 μg/ml peptide in 200 μl IMDM (Gibco, Invitrogen) containing 10% FCS, penicillin/streptomycin and 50 μM 2-mercapto-ethanol. Brefeldin-A 10 μg/ml (Sigma, St. Louis, MO) was added for the duration of the stimulation to facilitate intracellular accumulation of cytokines. To determine the restriction element for the G [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] peptide, the cells were washed with PBS containing 2% FCS, 2 mM EDTA and 0.02% NaN 3 (FACS buffer) and surface stained for flow cytometric analysis. Before intracellular staining, cells were fixed and permeabilized with CytoFix/CytoPerm solution and Perm/Wash buffer (BD Pharmingen, San Diego, CA) according to instructions of the manufacturer.
Flow cytometric analysis of CD8
+ T cells MHC class I-peptide tetramers were produced as described (Haanen et al., 1999) . Freshly isolated BAL, lung or spleen lymphocytes were stained in FACS buffer, using fluorochromeconjugated antibodies and M [187] [188] [189] [190] [191] [192] [193] [194] [195] Influenza-MHC class I tetramers. The antibodies, anti-CD8 (clone 53-6.7), anti-CD11a (2D7), anti-CD62L (clone MEL-14) and anti-NKG2a (20D5) were used for cell surface staining. For intracellular IFN-γ staining, we used the rat-anti-mouse IFN-γ FITC (clone XMG 1.2). All antibodies were purchased from BD Pharmingen (San Diego, CA). Stained samples were acquired on a FACSCalibur flowcytometer (BD, San Diego, CA). Data were analyzed using CellQuest software (BD, San Diego, CA).
Statistical analysis
Data were analyzed for statistical significance using a Students t test. Data are expressed as the mean ± standard error of the mean (SEM). A P value <0.05 was taken as the level of significance.
